Sònia Servitja
Universitat Pompeu Fabra(ES)Instituto de Salud Carlos III(ES)Hospital Del Mar(ES)Centro de Investigación Biomédica en Red de Cáncer(ES)GEICAM – Spanish Breast Cancer Group(ES)
Publications by Year
Research Areas
HER2/EGFR in Cancer Research, Breast Cancer Treatment Studies, Cancer Treatment and Pharmacology, Advanced Breast Cancer Therapies, Estrogen and related hormone effects
Most-Cited Works
- → Nuclear PARP-1 protein overexpression is associated with poor overall survival in early breast cancer(2011)177 cited
- → NK Cell Infiltrates and HLA Class I Expression in Primary HER2+ Breast Cancer Predict and Uncouple Pathological Response and Disease-free Survival(2019)130 cited
- → Defective Cyclin B1 Induction in Trastuzumab-emtansine (T-DM1) Acquired Resistance in HER2-positive Breast Cancer(2017)94 cited
- → Interplay between Natural Killer Cells and Anti-HER2 Antibodies: Perspectives for Breast Cancer Immunotherapy(2017)88 cited
- → Vitamin D threshold to prevent aromatase inhibitor-induced arthralgia: a prospective cohort study(2010)86 cited
- → Breast cancer risk after diagnosis by screening mammography of nonproliferative or proliferative benign breast disease: a study from a population-based screening program(2014)